CA3054690A1 - Compositions selectionnees de maniere ciblee comportant des cannabinoides purifies et/ou des terpenes purifies - Google Patents

Compositions selectionnees de maniere ciblee comportant des cannabinoides purifies et/ou des terpenes purifies Download PDF

Info

Publication number
CA3054690A1
CA3054690A1 CA3054690A CA3054690A CA3054690A1 CA 3054690 A1 CA3054690 A1 CA 3054690A1 CA 3054690 A CA3054690 A CA 3054690A CA 3054690 A CA3054690 A CA 3054690A CA 3054690 A1 CA3054690 A1 CA 3054690A1
Authority
CA
Canada
Prior art keywords
purified
cannabinoid
terpene
alpha
thc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3054690A
Other languages
English (en)
Inventor
Kurt LEVY
Jonathan Michael COOPER
Jonathan Reed MARTIN
Brian Geoffrey REID
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canopy Growth Corp
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/616,874 external-priority patent/US20170266153A1/en
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of CA3054690A1 publication Critical patent/CA3054690A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne de nouvelles compositions comportant un cannabinoïde purifié et un terpène purifié. Dans un mode de réalisation, les compositions comportent un ou plusieurs cannabinoïdes purifiés. Dans un mode de réalisation, les compositions comportent un ou plusieurs cannabinoïdes purifiés en combinaison avec un ou plusieurs terpènes purifiés. Dans un mode de réalisation, les compositions comportent des rapports ne se produisant pas naturellement. Dans un mode de réalisation, les compositions comportent des concentrations ne se produisant pas naturellement. Dans un mode de réalisation, les compositions comportent des effets inattendus et/ou synergiques.
CA3054690A 2017-03-01 2018-03-01 Compositions selectionnees de maniere ciblee comportant des cannabinoides purifies et/ou des terpenes purifies Pending CA3054690A1 (fr)

Applications Claiming Priority (35)

Application Number Priority Date Filing Date Title
US201762465688P 2017-03-01 2017-03-01
US62/465,688 2017-03-01
US201762469415P 2017-03-09 2017-03-09
US62/469,415 2017-03-09
US201762475153P 2017-03-22 2017-03-22
US62/475,153 2017-03-22
US201762477990P 2017-03-28 2017-03-28
US62/477,990 2017-03-28
US201762489360P 2017-04-24 2017-04-24
US62/489,360 2017-04-24
US201762490567P 2017-04-26 2017-04-26
US201762490465P 2017-04-26 2017-04-26
US62/490,567 2017-04-26
US62/490,465 2017-04-26
US201762491160P 2017-04-27 2017-04-27
US201762491175P 2017-04-27 2017-04-27
US62/491,160 2017-04-27
US62/491,175 2017-04-27
US201762491980P 2017-04-28 2017-04-28
US201762491899P 2017-04-28 2017-04-28
US62/491,980 2017-04-28
US62/491,899 2017-04-28
US201762509651P 2017-05-22 2017-05-22
US62/509,651 2017-05-22
US201762510229P 2017-05-23 2017-05-23
US62/510,229 2017-05-23
US201762510672P 2017-05-24 2017-05-24
US201762510660P 2017-05-24 2017-05-24
US62/510,672 2017-05-24
US62/510,660 2017-05-24
US201762511218P 2017-05-25 2017-05-25
US62/511,218 2017-05-25
US15/616,874 2017-06-07
US15/616,874 US20170266153A1 (en) 2015-02-27 2017-06-07 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
PCT/US2018/020440 WO2018160827A1 (fr) 2017-03-01 2018-03-01 Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés

Publications (1)

Publication Number Publication Date
CA3054690A1 true CA3054690A1 (fr) 2018-09-07

Family

ID=63370542

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3054690A Pending CA3054690A1 (fr) 2017-03-01 2018-03-01 Compositions selectionnees de maniere ciblee comportant des cannabinoides purifies et/ou des terpenes purifies

Country Status (10)

Country Link
EP (1) EP3589129A4 (fr)
CN (1) CN110582206A (fr)
AU (1) AU2018227544A1 (fr)
BR (1) BR112019018088A2 (fr)
CA (1) CA3054690A1 (fr)
CO (1) CO2019009413A2 (fr)
IL (1) IL268929A (fr)
MX (1) MX2019010370A (fr)
PE (1) PE20200383A1 (fr)
WO (1) WO2018160827A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031123C (fr) 2018-01-23 2023-11-07 High Sierra Technologies, Inc. Produits de cannabis modifies par l'enlevement des composes organiques volatils et l'ajout d'hydrocarbures insatures volatils
IL266151A (en) * 2019-04-18 2019-07-31 Kanabo Res Ltd Dilute for the cannabinoid preparations
CA3148236A1 (fr) 2019-07-22 2021-01-28 Canopy Growth Corporation Cristallisation continue de cannabinoides dans un reacteur a cuve agitee
IL293403A (en) * 2019-11-26 2022-07-01 Lycored Ltd Synergistic anti-inflammatory combinations of cannabinoid and lycopene
WO2021220208A1 (fr) * 2020-04-29 2021-11-04 Ligar Limited Partnership Polymères à empreinte et procédés pour leur utilisation
US20230146330A1 (en) * 2020-07-27 2023-05-11 Canopy Growth Corporation Methods of synthesizing cannabielsoin and analogs thereof
WO2022165165A1 (fr) * 2021-01-29 2022-08-04 The Johns Hopkins University Effets de limonène sur l'anxiété induite par tétrahydrocannabinol (thc)
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
WO2023245185A1 (fr) * 2022-06-17 2023-12-21 New Growth Brands, Inc. Compositions comprenant des cannabinoïdes et leurs procédés de préparation et d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
CA2931039C (fr) * 2013-11-20 2022-07-12 Mary Lynch Compositions et methodes de traitement de l'inflammation oculaire et de la douleur
US20160250270A1 (en) * 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral

Also Published As

Publication number Publication date
AU2018227544A1 (en) 2019-08-29
PE20200383A1 (es) 2020-02-24
CN110582206A (zh) 2019-12-17
WO2018160827A1 (fr) 2018-09-07
IL268929A (en) 2019-10-31
BR112019018088A2 (pt) 2020-03-24
EP3589129A4 (fr) 2020-11-25
EP3589129A1 (fr) 2020-01-08
MX2019010370A (es) 2019-10-22
CO2019009413A2 (es) 2019-09-09

Similar Documents

Publication Publication Date Title
US20210220323A1 (en) Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene or mineral
CA3054690A1 (fr) Compositions selectionnees de maniere ciblee comportant des cannabinoides purifies et/ou des terpenes purifies
CA2977802A1 (fr) Compositions comprenant des combinaisons de cannabinoides purifies, ayant au moins un flavonoide, terpene ou mineral
Bicas et al. Volatile constituents of exotic fruits from Brazil
US11338222B2 (en) Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
Asikin et al. The composition of volatile aroma components, flavanones, and polymethoxylated flavones in Shiikuwasha (Citrus depressa Hayata) peels of different cultivation lines
EP3261629A1 (fr) Compositions comprenant des combinaisons de cannabinoïdes purifiés, ayant au moins un flavonoïde, terpène ou minéral
Alighiri et al. Study on the improvement of essential oil quality and its repellent activity of betel leaves oil (Piper betle l.) from Indonesia
WO2017100369A1 (fr) Compositions de cannabinoïdes et de terpènes imprimables
Benkhoud et al. Essential oils as flavoring and preservative agents: Impact on volatile profile, sensory attributes, and the oxidative stability of flavored extra virgin olive oil
Rowshan et al. Changes of peel essential oil composition of Citrus aurantium L. during fruit maturation in Iran
Butnariu Plants as source of essential oils and perfumery applications
CA3106717A1 (fr) Composes organiques volatils contenant du soufre dans le cannabis
Lis et al. Comparison of chemical composition of the essential oils from different botanical organs of Pinus mugo growing in Poland
EP3761821A1 (fr) Dispositif et procédé d'administration de principes actifs
del Refugio Ramos-Jerz Phytochemical analysis of avocado seeds (Persea americana Mill., cv Hass)
US20240090545A1 (en) Citrus modifier compounds in cannabis
Tomaszewski Identification of the key aroma active compounds of propolis collected from central New Jersey over three consecutive years
US11602701B2 (en) Method for extraction and isolation of cannabis terpene and aromatic isolates from cannabis sativa and cannabis indica
MIYA PHYTOCHEMICAL STUDIES OF LEAVES AND PEELS OF LEMON AND THREE SPECIES OF GRAPE AND THEIR BIOLOGICAL ACTIVITIES
Marrellia et al. NPC Natural Product Communications 2018
Moreno-Chamba et al. Aromatic and cannabinoid profiles of Cannabis inflorescences and seed oils: A comprehensive approach for variety characterization
Ruas Chemical characterization and bioactivity of commercial essential oils obtained from Portuguese logging residues and thinnings
WO2021179088A1 (fr) Compositions enrichies en terpène et leurs utilisations
Daluiso An evaluation of sustainable sub-and supercritical fluid extraction technologies and traditional soxhlet for the isolation of high quality, natural Lavandula spp. Flavours